Pasithea Therapeutics logo

Pasithea Therapeutics Share Price (NASDAQ: KTTA)

$0.81

▲

-0.03

(-3.57%)

Last updated on

Check the interactive Pasithea Therapeutics Stock chart to analyse performance

Pasithea Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.76
    Today's High:$0.81

    Day's Volatility :6.23%

  • 52 Weeks Low:$0.65
    52 Weeks High:$7.50

    52 Weeks Volatility :91.33%

Pasithea Therapeutics Stock Returns

PeriodPasithea Therapeutics CorpIndex (Russel 2000)
3 Months
-12.85%
0.0%
6 Months
-26.32%
0.0%
1 Year
-83.29%
0.0%
3 Years
-96.48%
-4.1%

Pasithea Therapeutics Corp Key Stats

Check Pasithea Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.84
Open
$0.8
Today's High
$0.8105
Today's Low
$0.76
Market Capitalization
$6.3M
Today's Volume
$296.9K
52 Week High
$7.5
52 Week Low
$0.65
Revenue TTM
$486.6K
EBITDA
$-13.1M
Earnings Per Share (EPS)
$-7.13
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-85.84%

Stock Returns calculator for Pasithea Therapeutics Stock including INR - Dollar returns

The Pasithea Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pasithea Therapeutics investment value today

Current value as on today

₹21,985

Returns

₹78,015

(-78.01%)

Returns from Pasithea Therapeutics Stock

₹83,299 (-83.3%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Pasithea Therapeutics Stock

45%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Pasithea Therapeutics Stock from India on INDmoney has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pasithea Therapeutics Corp

  • Name

    Holdings %

  • AdvisorShares Investments, LLC

    2.60%

  • UBS Group AG

    0.06%

  • Hurley Capital, LLC

    0.05%

  • Tower Research Capital LLC

    0.02%

Analyst Recommendation on Pasithea Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pasithea Therapeutics(by analysts ranked 0 to 5 stars)

Pasithea Therapeutics Share Price Target

What analysts predicted

Upside of 146.91%

Target:

$2.00

Current:

$0.81

Pasithea Therapeutics share price target is $2.00, a slight Upside of 146.91% compared to current price of $0.81 as per analysts' prediction.

Pasithea Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, KTTA stock has moved up by 13.0%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 976.30K → 649.02K (in $), with an average decrease of 33.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -2.99M → -3.71M (in $), with an average decrease of 7.5% per quarter

  • KTTA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 152.1%

  • KTTA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 212.5%

  • Price to Sales

    ForKTTA every $1 of sales, investors are willing to pay $2.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Pasithea Therapeutics Technicals Summary

Sell

Neutral

Buy

Pasithea Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Pasithea Therapeutics Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pasithea Therapeutics Corp logo
Pasithea Therapeutics Corp
16.08%
-26.32%
-83.29%
-96.48%
-98.86%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
Beone Medicines Ltd
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
11.08%
83.28%
75.87%
111.28%
242.25%

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Organization
Pasithea Therapeutics
Employees
4
CEO
Dr. Tiago Reis Marques M.D., Ph.D.
Industry
Miscellaneous

Key Management of Pasithea Therapeutics Corp

NameTitle
Dr. Lawrence Steinman BA, M.D., Ph.D.
Co-Founder, MD & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.
CEO & Director
Mr. Daniel H. Schneiderman
Chief Financial Officer

Important FAQs about investing in KTTA Stock from India :

What is Pasithea Therapeutics share price today?

Pasithea Therapeutics share price today is $0.81 as on at the close of the market. Pasithea Therapeutics share today touched a day high of $0.81 and a low of $0.76.

What is the 52 week high and 52 week low for Pasithea Therapeutics share?

Pasithea Therapeutics share touched a 52 week high of $7.50 and a 52 week low of $0.65. Pasithea Therapeutics stock price today i.e. is closed at $0.81, lower by 89.2% versus the 52 week high.

How to invest in Pasithea Therapeutics Stock (KTTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pasithea Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pasithea Therapeutics Shares that will get you 1.8519 shares as per Pasithea Therapeutics share price of $0.81 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pasithea Therapeutics Stock (KTTA) from India?

Indian investors can start investing in Pasithea Therapeutics (KTTA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Pasithea Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Pasithea Therapeutics share’s latest price of $0.81 as on August 30, 2025 at 1:29 am IST, you will get 12.3457 shares of Pasithea Therapeutics. Learn more about fractional shares .

What are the returns that Pasithea Therapeutics has given to Indian investors in the last 5 years?

Pasithea Therapeutics stock has given -98.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?